Compile Data Set for Download or QSAR
Report error Found 277 Enz. Inhib. hit(s) with all data for entry = 4291
TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403946BDBM403946((2S,5R)-1-(2'-chloro-2-methoxy-[1,1'-biphenyl]-4-c...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403949BDBM403949((2S,5R)-5-(2-chlorophenyl)-1-(4-(2-methylthiophen-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403960BDBM403960((2S,5R)-5-(2-chlorophenyl)-1-(2',6'-dichloro-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403941BDBM403941((2S,5R)-5-(2-chlorophenyl)-1-(2',4'-dimethoxy-[1,1...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403945BDBM403945((2S,5R)-1-(2-chloro-[1,1'-biphenyl]-4-carbonyl)-5-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403937BDBM403937((2S,5R)-5-(2-chlorophenyl)-1-(2'-(trifluoromethyl)...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403938BDBM403938((2S,5R)-5-(2-chlorophenyl)-1-(2,2'-dimethoxy-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403939BDBM403939((2S,5R)-1-(4'-chloro-2'-methoxy-[1,1'-biphenyl]-4-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403931BDBM403931((2S,5R)-5-(2-chlorophenyl)-1-(2-methoxy-[1,1'-biph...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403932BDBM403932((2S,5R)-5-(2-chlorophenyl)-1-(2'-cyano-[1,1'-biphe...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403933BDBM403933((2S,5R)-5-(2-chlorophenyl)-1-(2',6'-dimethoxy-[1,1...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403936BDBM403936((2S,5R)-5-(2-chlorophenyl)-1-(2',4'-dichloro-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403985BDBM403985((2S,5R)-5-(2-fluorophenyl)-1-(4-(2-methoxypyridin-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403987BDBM403987((2S,5R)-1-(4-(2,4-dimethoxypyrimidin-5-yl)benzoyl)...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403989BDBM403989((2S,35,5S)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403967BDBM403967((2S,5R)-5-(2-chlorophenyl)-1-(2'-(methoxymethyl)-[...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403968BDBM403968((2S,5R)-5-(2-chlorophenyl)-1-(4-(2,6-dimethoxypyri...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403961BDBM403961((2S,5R)-1-(2'-chloro-4'-methoxy-[1,1'-biphenyl]-4-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403964BDBM403964((2S,5R)-5-(2-fluorophenyl)-1-(2'-methoxy-[1,1'-bip...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404054BDBM404054((2S,5R)-1-(4-(2-chloro-4-methoxypyrimidin-5-yl)ben...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403997BDBM403997((2S,5R)-5-(3-fluorophenyl)-1-(2'-methoxy-[1,1'-bip...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 403991BDBM403991((2S,5R)-1-(4-(2,6-dimethoxypyridin-3-yl)benzoyl)-5...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404110BDBM404110((2S,5R)-5-(2-chlorophenyl)-1-(4-(6-methoxy-2-methy...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404101BDBM404101((2S,5R)-5-(2-chlorophenyl)-1-(2-fluoro-[1,1'-biphe...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404102BDBM404102((2S,5R)-5-(2-chlorophenyl)-1-(2'-fluoro-4'-methoxy...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404105BDBM404105((2S,5R)-5-(2-chlorophenyl)-1-(4'-fluoro-2'-methoxy...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404091BDBM404091((2S,5R)-5-(2-chlorophenyl)-1-(2',4'-difluoro-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404093BDBM404093((2S,5R)-5-(2-chlorophenyl)-1-(2-methyl-[1,1'-biphe...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404095BDBM404095((2S,5R)-5-(2,4-difluorophenyl)-1-(2'-methoxy-[1,1'...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404144BDBM404144((2S,5R)-5-(2-chlorophenyl)-1-(4-(2,6-dimethylpyrid...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404137BDBM404137((2S,5R)-1-(2,2'-dimethoxy-[1,1'-biphenyl]-4-carbon...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404138BDBM404138((2S,5R)-1-(2-fluoro-2'-methoxy-[1,1'-biphenyl]-4-c...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404139BDBM404139((2S,5R)-5-(2-chlorophenyl)-1-(2-fluoro-2'-methoxy-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404133BDBM404133((2S,5R)-5-(2-chlorophenyl)-1-(3',5'-dimethoxy-[1,1...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404134BDBM404134((2S,5R)-5-(2-chlorophenyl)-1-(2',5'-dimethoxy-[1,1...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404122BDBM404122((2S,5R)-5-(2-chlorophenyl)-1-(2',3'-dimethoxy-[1,1...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404124BDBM404124((2S,5R)-5-(2-chlorophenyl)-1-(3',4'-dimethoxy-[1,1...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404170BDBM404170((2S,5R)-5-(2-chlorophenyl)-1-(4-(2,4-dimethoxypyri...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404156BDBM404156((2S,5R)-5-(2-chlorophenyl)-1-(3-methoxy-4-(6-metho...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404152BDBM404152((2S,5R)-1-(3-chloro-4-(2,4-dimethoxypyrimidin-5-yl...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404184BDBM404184((2S,5R)-5-(2-chlorophenyl)-1-(2'-methoxy-4'-(methy...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404185BDBM404185((2S,5R)-1-(4'-acetamido-2'-methoxy-[1,1'-biphenyl]...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404180BDBM404180((2S,5R)-5-(2-chlorophenyl)-1-(5'-cyano-2'-methyl-[...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404181BDBM404181((2S,5R)-5-(2-chlorophenyl)-1-(4-(4,6-dimethoxypyri...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404182BDBM404182((2S,5R)-5-(2-chlorophenyl)-1-(4-(3,6-dimethoxypyri...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404176BDBM404176((2S,5R)-1-(3'-amino-2'-methyl-[1,1'-biphenyl]-4-ca...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404177BDBM404177((2S,5R)-5-(2-chlorophenyl)-1-(2'-methyl-3'-(methyl...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404179BDBM404179((2S,5R)-5-(2-chlorophenyl)-1-(5'-cyano-2'-methoxy-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404171BDBM404171((2S,5R)-5-(2-bromophenyl)-1-(2'-methoxy-[1,1'-biph...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetFree fatty acid receptor 2(Human)
Ogeda

US Patent
LigandChemical structure of BindingDB Monomer ID 404174BDBM404174((2S,5R)-5-(2-chlorophenyl)-1-(3'-cyano-2'-methoxy-...)
Affinity DataEC50: <200nMAssay Description:The following assay can be used for determination of GPR43 activation. When a GPCR is in its active state, either as a result of ligand binding or co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

Displayed 1 to 50 (of 277 total ) | Next | Last >>
Jump to: